Gli1 has also been found to play a role in expression of ABC transporters ABCG1 and ABCG2 by directly binding to their promoter regions resulting in increased resistance to both cisplatin and paclitaxel in spheroid forming of ovarian cancer cells [61, 62]. Here, ABCG2 is linked to ovarian cancer.